Recently, the 18th Research Institute of the First Academy of the Aerospace Science and Technology Group established a wholly-owned subsidiary — Aerospace New Long March Medical Instrument (Beijing) Co., Ltd., marking that the high-end medical equipment ECMO (Extracorporeal Membrane Oxygenation) developed by the institute has begun to enter industrialization.
It is reported that Aerospace New Long March Medical Instrument (Beijing) Co., Ltd. is mainly responsible for the development of high-end medical equipment ECMO. The company is committed to building a high-end medical equipment platform, accelerating the tackling of key core technologies, product research and development, and industrial application, and promoting the domestic production of ECMO in China. Currently, the company has completed the prototype development work. Subsequently, it will continue to leverage its aerospace servo technology advantages to develop a series of high-end medical products. (Li Xinyun)